State Street’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

State Street’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-101	Closed	-$7.65K	–	4409
2024 Q1	$7.65K	Hold	101	–	–	﹤0.01%	4338
2023 Q4	$18K	Sell	101 -1	-1%	-$492	﹤0.01%	4352
2023 Q3	$72.4K	Buy	102 +20	+24%	+$85.8K	﹤0.01%	4194
2023 Q2	$376K	Hold	82	–	–	﹤0.01%	3777
2023 Q1	$217K	Hold	82	–	–	﹤0.01%	4052
2022 Q4	$213K	Hold	82	–	–	﹤0.01%	4075
2022 Q3	$324K	Hold	82	–	–	﹤0.01%	3937
2022 Q2	$214K	Sell	82 -372	-82%	-$969K	﹤0.01%	4166
2022 Q1	$1.46M	Buy	454 +22	+5%	+$94.6K	﹤0.01%	3678
2021 Q4	$2.71M	Buy	432 +21	+5%	+$161K	﹤0.01%	3544
2021 Q3	$3.81M	Buy	411 +104	+34%	+$894K	﹤0.01%	3370
2021 Q2	$3.11M	Buy	+307	New	+$5.04M	﹤0.01%	3449
2016 Q4	–	Hold	0	–	-$4K	–	3690
2016 Q3	–	Hold	0	–	–	–	3591
2016 Q2	–	Hold	0	–	–	–	3719
2016 Q1	–	Hold	0	–	–	–	3715
2015 Q4	–	Hold	0	–	–	–	3698
2015 Q3	–	Hold	0	–	–	–	3676
2015 Q2	–	Hold	0	–	–	–	3684
2015 Q1	–	Hold	0	–	–	–	3640
2014 Q4	–	Hold	0	–	–	–	3673
2014 Q3	–	Hold	0	–	–	–	3655
2014 Q2	–	Hold	0	–	–	–	3594
2014 Q1	–	Hold	0	–	–	–	3602
2013 Q4	–	Hold	0	–	–	–	3573
2013 Q3	–	Hold	0	–	–	–	3575
2013 Q2	–	Hold	0	–	–	–	3496

Other funds holding SEEL

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CHA

Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street's SEEL Position: Q2 2024 in Review

State Street sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2024, closing a stake of 101 shares — an estimated $7.65K sold.

State Street first reported a position in SEEL in Q2 2021 and held it in 12 quarters. The position peaked at $3.81M in Q3 2021. 18 funds tracked by Wall St. Rank hold SEEL as of Q2 2024.

State Street reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
State Street sold 101 Seelos Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $7.65K.
State Street first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
State Street's Seelos Therapeutics, Inc. Common Stock position peaked at $3.81M in Q3 2021.
18 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.